Clora celebrates Pathos closing funding
Pathos secured $237 million Series E led by Bristol Myers Squibb to scale its Foundry platform and advance Alzheimer's drug development.
See the latest news and media coverage for Clora. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences talent marketplace
clora.comLast updated
In short: Clora highlighted major biotech milestones, including FDA approvals, trial successes, and AI collaborations.
Pathos secured $237 million Series E led by Bristol Myers Squibb to scale its Foundry platform and advance Alzheimer's drug development.
The drug met its primary endpoint in acute bipolar mania, demonstrating significant improvement over placebo. Phase 3 trials are planned for late 2027.
The platform benchmarks consultant rates against full-time hire costs using data from its 15,000+ vetted consultant network.
Recent deals underscore industry growth. Clora solves specialist access issues for manufacturing, quality, and regulatory teams.
Clora is building the future of work in the life sciences. By combining the two companies, Clora will continue to expand its global talent operations...
At the 12th annual fall conference for Health 2.0, QuartzClinical announced the launch of the latest version of its sophisticated healthcare data analytics platform. Intended...
On-demand labor marketplaces have been around for decades on the internet. Paying someone to identify a cat using Amazon Mechanical Turk or hiring someone to...
It often takes about 14 years and $2 billion to develop a drug and get it into the hands of doctors and patients. However, a...
Track Clora and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Clora and other trending companies.